Expression profile of malignant and nonmalignant lesions of esophagus and stomach: Differential activity of functional modules related to inflammation and lipid metabolism

Cancer Research

Volumn 65, Issue 16, 2005, Pages 7127-7136

  Gomes, Luciana I ^a   Esteves, Gustavo H ^a   Carvalho, Alex F ^a   Cristo, Elier B ^a   Hirata Jr , Roberto ^a   Martins, Waleska K ^a   Marques, Sarah M ^a   Camargo, Luiz P ^a   Brentani, Helena ^a   Pelosof, Adriane ^a   Zitron, Cláudia ^a   Sallum, Rubens A ^a   Montagnini, André ^a   Soares, Fernando A ^a   Neves, E Jordão ^a   Reis, Luiz F L ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; COLUMNAR EPITHELIUM; DISEASE CLASSIFICATION; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GENE EXPRESSION PROFILING; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE METAPLASIA; LIPID METABOLISM; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; STOMACH CANCER;

ADENOCARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LIPID METABOLISM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 23844431579     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1035     Document Type: Article

References (48)

1. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004;4:11-22.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
3. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004;431:405-6.
4. Mueller J, Werner M, Stolte M. Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg 2004;28:148-54.
5. Forman D. Review article: oesophago-gastric adenocarcinoma-an epidemiological perspective. Aliment Pharmacol Ther 2004;20:55-60.
6. Souza RF, Morales CP, Spechler SJ. Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus. Aliment Pharmacol Ther 2001;15:1087-100.
7. Falk GW. Barrett's esophagus. Gastroenterology 2002;122:1569-91.
8. Caygill CP, Watson A, Lao-Sirieix P, Fitzgerald RC. Barrett's oesophagus and adenocarcinoma. World J Surg Oncol 2004;2:12.
9. Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003;3:676-84.
10. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-85.
11. Jankowski JA, Anderson M. Review article: management of oesophageal adenocarcinoma-control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus. Aliment Pharmacol Ther 2004;20: 71-80.
12. Farthing MJ, Fitzgerald R, Zhang ZW. Acid, Helicobacter and immunity: a new paradigm for oesophagogastric cancer. J Physiol Paris 2001;95:423-7.
13. Olliver JR, Hardie LJ, Dexter S, Chalmers D, Wild CP. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 2003;8:509-21.
14. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004;311-26.
15. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
16. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
17. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-73.
18. Segal E, Shapira M, Regev A, et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 2003;34:166-76.
19. Segal E, Friedman N, Koller D, Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004;36:1090-8.
20. Lauren P. The two histological main types of gastric carcinoma: difuse and so-called intestinal-type carcinoma. An attempt at histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
21. Gomes LI, Silva RL, Stolf BS, et al. Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray. Anal Biochem 2003;321:244-51.
22. Carvalho AF, Neves EJ, Hirata JR, Reis LF. Glass slide-based agarose gel electrophoresis for determining the efficiency of RNA amplification and cyanine dye incorporation during RNA labeling. Biotechniques 2003;35:688-90, 692.
23. Brentani RR, Carraro DM, Verjovski-Almeida S, et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 2005;54:95-105.
24. Zar J. Biostatistical analysis. 2nd ed. Englewood Cliff, NJ: Prentice Hall;1998.
25. Meireles SI, Cristo EB, Carvalho AF, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004;64:1255-65.
26. Abdalla EK, Pisters PW. Staging and preoperative evaluation of upper gastrointestinal malignancies. Semin Oncol 2004;31:513-29.
27. Rudiger SJ, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-61.
28. Motoki K, Megahed M, LaForgia S, Uitto J. Cloning and chromosomal mapping of mouse ladinin, a novel basement membrane zone component. Genomics 1997;39:323-30.
29. Leube RE, Bader BL, Bosch FX, Zimbelmann R, Achtstaetter T, Franke WW. Molecular characterization and expression of the stratification-related cytokeratins 4 and 15. J Cell Biol 1988;106:1249-61.
30. Ruhrberg C, Hajibagheri MA, Parry DA, Watt FM. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 1997;139: 1835-49.
31. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001;276:18327-36.
32. Shibata T, Ochiai A, Gotoh M, Machinami R, Hirohashi S. Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett 1996;99:147-53.
33. Chen HC, Chu RY, Hsu PN, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 2003;201:97-106.
34. Oliveira C, de Bruin J, Nabais S, et al. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 2004;23: 2236-40.
35. Boussioutas A, Li H, Liu J, et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 2003;63:2569-77.
36. Eksteen JA, Scott PA, Perry I, Jankowski JA. Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFα. Eur J Cancer Prev 2001;10:163-6.
37. Bartsch H, Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect Prev 2004;28:385-91.
38. Cejas P, Casado E, Belda-Iniesta C, et al. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 2004;15:707-19.
39. Cao D, Fan ST, Chung SS. Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 1998;273:11429-35.
40. Rizzo WB, Lin Z, Carney G. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjogren-Larsson syndrome. Chem Biol Interact 2001;132:297-307.
41. Duester G, Farres J, Felder MR, et al. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem Pharmacol 1999;58:389-95.
42. Cao D, Hustinx SR, Sui G, et al. Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a Bioinformatics Analysis of Expressed Sequence Tags. Cancer Biol Ther 2004;3:1081-9.
43. Brown CW, Li L, Houston-Hawkins DE, Matzuk MM. Activins are critical modulators of growth and survival. Mol Endocrinol 2003;17:2404-17.
44. Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin MU. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol 1998;161:6871-7.
45. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003;9:756-61.
46. Wang L, Mizzen C, Ying C, et al. Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation. Mol Cell Biol 1997;17:519-27.
47. Butte AJ, Tamayo P, Slonim D, Golub TR, Kohane IS. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc Natl Acad Sci U S A 2000;97: 12182-6.
48. Moriyama M, Hoshida Y, Otsuka M, et al. Relevance network between chemosensitivity and transcriptome in human hepatoma cells. Mol Cancer Ther 2003;2:199-205.